Clovis Oncology (CLVS) Stock Rating Lowered by BidaskClub

James Marshall
January 28, 2018

PNC Financial Services Group Inc. increased its holdings in Clovis Oncology by 0.7% in the 2nd quarter. It has outperformed by 266.01% the S&P500. (NYSE:T). Northstar Investment Lc reported 25,540 shares. The shares were sold at an average price of $59.16, for a total value of $177,480.00. (ABBV)'s stock rose 6.17%. Cypress Capital Management LLC WY now owns 2,050 shares of the biopharmaceutical company's stock valued at $169,000 after buying an additional 1,500 shares in the last quarter. Abbvie Inc. now has $169.86 billion valuation. The stock increased 2.08% or $0.09 during the last trading session, reaching $4.41. About 842,616 shares traded.

Clovis Oncology (NASDAQ:CLVS) last announced its quarterly earnings results on Wednesday, November 1st. It has underperformed by 30.49% the S&P500. The rating was initiated by Loop Capital with "Buy" on Friday, September 23. The insider RENFRO LARRY C sold $5.01M. Zuckerberg Mark sold $42.50M worth of stock or 249,527 shares. On Monday, September 11 the insider SALEKI-GERHARDT AZITA sold $705,655. FISCHER DAVID B. sold $2.75M worth of stock. Shares for $1.12M were sold by WILENSKY GAIL R. It increased, as 77 investors sold T shares while 609 reduced holdings.

Among 4 analysts covering Bancorp (NASDAQ:TBBK), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 52% are positive. UnitedHealth Group had 79 analyst reports since September 2, 2015 according to SRatingsIntel. The firm earned "Sell" rating on Monday, December 5 by Citigroup. As per Wednesday, March 2, the company rating was maintained by Barclays Capital. The firm has "Outperform" rating by Robert W. Baird given on Thursday, July 30. The stock of AbbVie Inc. (NASDAQ:FB) earned "Buy" rating by Cowen & Co on Tuesday, October 31. The stock has "Buy" rating by Suntrust Robinson on Friday, August 5. The firm has "Buy" rating by WallachBeth Capital given on Thursday, September 10. The rating was maintained by Mizuho on Wednesday, October 19 with "Buy".

Analysts await AT&T Inc. (NYSE:ABBV) to report earnings on January, 26. Kinross Gold Corp now has $5.39B valuation. The biopharmaceutical company reported ($1.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($1.18) by ($0.06). Its down 0.37, from 1.81 in 2017Q2. It is negative, as 53 investors sold FB shares while 618 reduced holdings. 37 funds opened positions while 117 raised stakes. Highlander Cap Management accumulated 300 shares or 0.02% of the stock.

Clovis Oncology (CLVS) opened at $60.67 on Friday. (NYSE:ABBV) for 17,930 shares. Moreover, Kbc Grp Nv has 0.03% invested in Clovis Oncology, Inc. (NYSE:ABBV) for 195,098 shares. Prudential Fin Incorporated has 0.05% invested in Symantec Corporation (NASDAQ:SYMC) for 871,634 shares. 3,000 shares were sold by IVERS-READ GILLIAN C, worth $192,480 on Friday, December 15. Oppenheimer Asset Mgmt reported 14 shares. Corporate insiders own 12.50% of the company's stock. Yhb Investment Advsr Inc reported 25,771 shares. First Manhattan has 0.01% invested in Facebook, Inc. The Utah-based Utah Retirement has invested 1.65% in Facebook, Inc. Oppenheimer Asset Management invested in 0% or 14 shares. Sii Invs Wi reported 0.08% in AbbVie Inc. Alliancebernstein Ltd Partnership accumulated 0.06% or 961,777 shares. (NASDAQ:CLVS). Commonwealth Equity Serv has invested 0% in Clovis Oncology, Inc.

What Historical Figures Say About Clovis Oncology, Inc. Following the completion of the sale, the director now directly owns 21,118 shares in the company, valued at approximately $1,372,036.46. (NASDAQ:FB) for 2,701 shares. Gabelli Securities Inc acquired 8,700 shares as Clovis Oncology Inc Com (CLVS)'s stock declined 20.61%.

Investors sentiment increased to 1.97 in Q3 2017. Its down 0.37, from 1.81 in 2017Q2. Credit Suisse Ag who had been investing in Unitedhealth Group Inc for a number of months, seems to be bullish on the $235.82B market cap company.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Cleararc Capital Incorporated has 15,774 shares. According to the latest data, the consensus recommendation for Clovis Oncology, Inc. Westfield Management L P invested in 0.29% or 459,470 shares. Ameriprise Fincl reported 481,494 shares or 0.02% of all its holdings. 23,810 were accumulated by Chicago Equity Prtn Ltd Llc. Jennison Associates Limited Liability Co holds 0.05% of its portfolio in Clovis Oncology, Inc. During last 3 month period, -0.10% of total institutional ownership has changed in the company shares. (NASDAQ:TBNK). Salzhauer Michael owns 28,633 shares for 0.39% of their portfolio. 11,728 were reported by Sei Investments. Ledyard National Bank has invested 0.86% of its portfolio in Facebook, Inc. During the same period in the previous year, the company posted ($1.70) earnings per share. equities research analysts expect that Clovis Oncology, Inc. will post -7.65 EPS for the current year. $1.45M worth of Clovis Oncology, Inc. (NASDAQ:CLVS) for 29,044 shares. Chevy Chase Trust invested in 539,597 shares. Therefore 70% are positive. Facebook had 220 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley lowered their price objective on shares of Clovis Oncology from $89.00 to $86.00 and set an "overweight" rating on the stock in a report on Thursday, November 2nd. As per Monday, January 23, the company rating was maintained by Stifel Nicolaus. The stock presently has a consensus rating of "Hold" and a consensus price target of $90.43.

The market capitalization (Stock Price Multiply by Total Number of Outstanding Shares) for the company is reported at $2.79B. (NASDAQ:TBBK) shares were sold by Beach Walter T.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER